Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Goldspan Health review
Two structural problems sit above the price. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each with B12. That storefront then advertises the price as monthly while stating a new supply arrives automatically every four weeks, which makes a year thirteen charges rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 above what a monthly reading implies. Both were already at the higher end before that adjustment. What is genuinely solid: eleven protocol categories on a longevity platform, dispensing through licensed 503A and 503B pharmacies, and a flat price at any dose. The homepage's fifty-state claim is qualified by its own terms, and no time to first dose is published.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Goldspan Health at a glance
- Semaglutide
- $229 per 4 weeks
- Tirzepatide
- $299 per 4 weeks
- Coverage
- Contradicted on its own site: 50 states on the homepage, exceptions in the terms
- Start
- Not published
How we scored Goldspan Health
Each factor is read off Goldspan Health's published pricing, disclosures and intake flow, and the six roll up into the 52/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The weakest showing on speed — a slow published timeline, or none at all.
Tiered or opaque — the true monthly is hard to pin down up front.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
Limited or state-gated availability — confirm yours first.
Semaglutide and tirzepatide on one account — switch without re-signing.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- goldspanhealth.com
Two structural problems sit above the price. Goldspan publishes no figure anywhere on its own site — you follow a product link to a separate storefront to learn semaglutide is $229 and tirzepatide $299. And that storefront bills every four weeks while calling it monthly, so a year is thirteen charges: about $2,977 and $3,887, roughly $230 and $300 above a monthly reading. Both were already at the expensive end. Dispensing is through licensed 503A and 503B pharmacies, and the fifty-state claim is qualified by its own terms.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideInjection with B12, any doseAdvertised as monthly, shipped and charged every 4 weeks — thirteen charges a year, about $2,977, not $2,748. The figure appears nowhere on Goldspan's own site, only on the separate storefront its links lead to. | $229 | Injection with B12, any doseAdvertised as monthly, shipped and charged every 4 weeks — thirteen charges a year, about $2,977, not $2,748. The figure appears nowhere on Goldspan's own site, only on the separate storefront its links lead to. |
| Compounded tirzepatideInjection with B12, any doseSame 4-week cycle: about $3,887 a year across thirteen charges rather than $3,588. | $299 | Injection with B12, any doseSame 4-week cycle: about $3,887 a year across thirteen charges rather than $3,588. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Goldspan Health's public disclosures at last review and change often; confirm the current number on Goldspan Health's own site.
What we like
- A flat price at any dose
- Dispensing through licensed 503A and 503B pharmacies
- Sits inside a broad longevity platform of eleven protocol categories
- Both weight-loss protocols pair the molecule with B12
The caveats
- No price anywhere on Goldspan's own site — you must click out to a third-party storefront
- Billed every 4 weeks while advertised as monthly — thirteen charges a year
- The real annual cost is about $2,977 and $3,887, not $2,748 and $3,588
- Among the more expensive compounded options even before the cycle adjustment
- The homepage claims 50 states while the terms carve out exceptions
- No time to first dose, and nothing on pregnancy or postpartum timing
Goldspan Health for working moms: our verdict
Two structural problems sit above the price. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each with B12. That storefront then advertises the price as monthly while stating a new supply arrives automatically every four weeks, which makes a year thirteen charges rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 above what a monthly reading implies. Both were already at the higher end before that adjustment. What is genuinely solid: eleven protocol categories on a longevity platform, dispensing through licensed 503A and 503B pharmacies, and a flat price at any dose. The homepage's fifty-state claim is qualified by its own terms, and no time to first dose is published. It runs about $229/4 weeks, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Goldspan Health the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Goldspan Health will cost you
- Compounded semaglutide — Injection with B12, any dose: $229/4 wks
- Compounded tirzepatide — Injection with B12, any dose: $299/4 wks
For context, the typical ongoing price across our roster is around $179/month, so Goldspan Health sits at the premium end.
The medications Goldspan Health prescribes
Goldspan Health prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Goldspan Health fits — and where it doesn't — for working moms
Right for you if…
- you want a flat price that doesn't climb every time you titrate up a dose.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Goldspan Health is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Someone already on peptide protocols who wants a GLP-1 on the same platform, and who will run the thirteen-payment math before comparing.
Alternatives to Goldspan Health
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Goldspan Health
Head-to-head & alternatives
Goldspan Health, answered
- Why is there no price on the site?
- There is not one. The homepage and weight-loss category page carry no dollar figure. Every product links out to a separate storefront on another domain, where the price finally appears — $229 semaglutide and $299 tirzepatide, both with B12. Buying from one company through another's checkout is worth knowing in advance.
- What does the 4-week cycle cost?
- Roughly one extra payment a year. The storefront advertises monthly pricing but states a new supply arrives automatically every four weeks — thirteen shipments a year, not twelve. Semaglutide is about $2,977 a year instead of $2,748; tirzepatide about $3,887 instead of $3,588.
- Is it available in every state?
- Not by its own account. The homepage says "In 50 states" and the terms say some therapies are unavailable in certain states. The claim and the qualification live in different documents, so confirm the specific protocol is offered where you live.
Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.